Lamont B Koo
Examiner (ID: 8622, Phone: (571)272-0984 , Office: P/2823 )
Most Active Art Unit | 2813 |
Art Unit(s) | 2813, 2823 |
Total Applications | 538 |
Issued Applications | 377 |
Pending Applications | 55 |
Abandoned Applications | 106 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 4778357
[patent_doc_number] => 20080286355
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-20
[patent_title] => 'Protease Inhibitors For the Treatment of Digestive Pathologies'
[patent_app_type] => utility
[patent_app_number] => 10/586085
[patent_app_country] => US
[patent_app_date] => 2005-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4590
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20080286355.pdf
[firstpage_image] =>[orig_patent_app_number] => 10586085
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/586085 | Protease Inhibitors For the Treatment of Digestive Pathologies | Jan 17, 2005 | Abandoned |
Array
(
[id] => 492293
[patent_doc_number] => 07211275
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-05-01
[patent_title] => 'Composite materials for controlled release of water soluble products'
[patent_app_type] => utility
[patent_app_number] => 11/034217
[patent_app_country] => US
[patent_app_date] => 2005-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 24804
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/211/07211275.pdf
[firstpage_image] =>[orig_patent_app_number] => 11034217
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/034217 | Composite materials for controlled release of water soluble products | Jan 12, 2005 | Issued |
Array
(
[id] => 6926453
[patent_doc_number] => 20050239709
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-27
[patent_title] => 'Synthetic antimicrobial polypeptides'
[patent_app_type] => utility
[patent_app_number] => 11/030232
[patent_app_country] => US
[patent_app_date] => 2005-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24115
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0239/20050239709.pdf
[firstpage_image] =>[orig_patent_app_number] => 11030232
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/030232 | Synthetic antimicrobial polypeptides | Jan 5, 2005 | Issued |
Array
(
[id] => 744466
[patent_doc_number] => 07026159
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-04-11
[patent_title] => 'Hyaluronate synthase gene and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/024426
[patent_app_country] => US
[patent_app_date] => 2004-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 10
[patent_no_of_words] => 21008
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/026/07026159.pdf
[firstpage_image] =>[orig_patent_app_number] => 11024426
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/024426 | Hyaluronate synthase gene and uses thereof | Dec 29, 2004 | Issued |
11/022296 | NOVEL HUMAN KIELIN-LIKE PROTEINS AND POLYNUCLEOTIDES ENCODING THE SAME | Dec 22, 2004 | Abandoned |
Array
(
[id] => 7250482
[patent_doc_number] => 20050142187
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-30
[patent_title] => 'Enhanced absorption of modified release dosage forms'
[patent_app_type] => utility
[patent_app_number] => 11/021309
[patent_app_country] => US
[patent_app_date] => 2004-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6367
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20050142187.pdf
[firstpage_image] =>[orig_patent_app_number] => 11021309
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/021309 | Enhanced absorption of modified release dosage forms | Dec 22, 2004 | Abandoned |
Array
(
[id] => 5648470
[patent_doc_number] => 20060134202
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-22
[patent_title] => 'Homeopathic sublingual dosage forms and methods thereof'
[patent_app_type] => utility
[patent_app_number] => 11/022093
[patent_app_country] => US
[patent_app_date] => 2004-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4212
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0134/20060134202.pdf
[firstpage_image] =>[orig_patent_app_number] => 11022093
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/022093 | Homeopathic sublingual dosage forms and methods thereof | Dec 21, 2004 | Abandoned |
Array
(
[id] => 740615
[patent_doc_number] => 07029860
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-04-18
[patent_title] => 'Amyloid-β protein aggregation-regulating factors'
[patent_app_type] => utility
[patent_app_number] => 11/013400
[patent_app_country] => US
[patent_app_date] => 2004-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10994
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/029/07029860.pdf
[firstpage_image] =>[orig_patent_app_number] => 11013400
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/013400 | Amyloid-β protein aggregation-regulating factors | Dec 16, 2004 | Issued |
Array
(
[id] => 558400
[patent_doc_number] => 07157428
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-01-02
[patent_title] => 'Method for treatment and repair of meniscal injuries'
[patent_app_type] => utility
[patent_app_number] => 10/998230
[patent_app_country] => US
[patent_app_date] => 2004-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 6228
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/157/07157428.pdf
[firstpage_image] =>[orig_patent_app_number] => 10998230
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/998230 | Method for treatment and repair of meniscal injuries | Nov 25, 2004 | Issued |
Array
(
[id] => 7039277
[patent_doc_number] => 20050158711
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-21
[patent_title] => 'Compositions and methods for protein isolation'
[patent_app_type] => utility
[patent_app_number] => 10/987388
[patent_app_country] => US
[patent_app_date] => 2004-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 16910
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0158/20050158711.pdf
[firstpage_image] =>[orig_patent_app_number] => 10987388
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/987388 | Compositions and methods for protein isolation | Nov 11, 2004 | Issued |
Array
(
[id] => 5776416
[patent_doc_number] => 20060105056
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-18
[patent_title] => 'Oxygenated albumin for use as blood and blood extender'
[patent_app_type] => utility
[patent_app_number] => 10/987787
[patent_app_country] => US
[patent_app_date] => 2004-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2318
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20060105056.pdf
[firstpage_image] =>[orig_patent_app_number] => 10987787
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/987787 | Oxygenated albumin for use as blood and blood extender | Nov 11, 2004 | Issued |
Array
(
[id] => 707469
[patent_doc_number] => 07060493
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-06-13
[patent_title] => 'Nod2 nucleic acids and proteins'
[patent_app_type] => utility
[patent_app_number] => 10/984710
[patent_app_country] => US
[patent_app_date] => 2004-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 16
[patent_no_of_words] => 41487
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/060/07060493.pdf
[firstpage_image] =>[orig_patent_app_number] => 10984710
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/984710 | Nod2 nucleic acids and proteins | Nov 8, 2004 | Issued |
Array
(
[id] => 672000
[patent_doc_number] => 07091008
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-08-15
[patent_title] => 'Hyaluronan synthase genes and expression thereof in Bacillus hosts'
[patent_app_type] => utility
[patent_app_number] => 10/981632
[patent_app_country] => US
[patent_app_date] => 2004-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 21
[patent_no_of_words] => 25952
[patent_no_of_claims] => 112
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/091/07091008.pdf
[firstpage_image] =>[orig_patent_app_number] => 10981632
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/981632 | Hyaluronan synthase genes and expression thereof in Bacillus hosts | Nov 4, 2004 | Issued |
Array
(
[id] => 7019326
[patent_doc_number] => 20050221345
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-06
[patent_title] => 'THIOREDOXIN H HOMOLOGS'
[patent_app_type] => utility
[patent_app_number] => 10/978538
[patent_app_country] => US
[patent_app_date] => 2004-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10390
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20050221345.pdf
[firstpage_image] =>[orig_patent_app_number] => 10978538
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/978538 | Thioredoxin H homologs | Oct 31, 2004 | Issued |
Array
(
[id] => 6938586
[patent_doc_number] => 20050112149
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-26
[patent_title] => 'Single-dose taste inhibitor units'
[patent_app_type] => utility
[patent_app_number] => 10/977805
[patent_app_country] => US
[patent_app_date] => 2004-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 1499
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0112/20050112149.pdf
[firstpage_image] =>[orig_patent_app_number] => 10977805
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/977805 | Single-dose taste inhibitor units | Oct 28, 2004 | Abandoned |
Array
(
[id] => 5590826
[patent_doc_number] => 20060040277
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-23
[patent_title] => 'Nucleic sequences encoding an AT2 receptor-interacting protein (ATIP) and their applications'
[patent_app_type] => utility
[patent_app_number] => 10/976933
[patent_app_country] => US
[patent_app_date] => 2004-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 7247
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0040/20060040277.pdf
[firstpage_image] =>[orig_patent_app_number] => 10976933
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/976933 | Nucleic sequences encoding an AT2 receptor-interacting protein (ATIP) and their applications | Oct 28, 2004 | Abandoned |
Array
(
[id] => 7231126
[patent_doc_number] => 20050079224
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-14
[patent_title] => 'Residual solvent extraction method and microparticles produced thereby'
[patent_app_type] => utility
[patent_app_number] => 10/956092
[patent_app_country] => US
[patent_app_date] => 2004-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10165
[patent_no_of_claims] => 70
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0079/20050079224.pdf
[firstpage_image] =>[orig_patent_app_number] => 10956092
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/956092 | Residual solvent extraction method and microparticles produced thereby | Oct 3, 2004 | Abandoned |
Array
(
[id] => 737520
[patent_doc_number] => 07034001
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-04-25
[patent_title] => 'Methods of therapy with thrombin derived peptides'
[patent_app_type] => utility
[patent_app_number] => 10/957427
[patent_app_country] => US
[patent_app_date] => 2004-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 5599
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/034/07034001.pdf
[firstpage_image] =>[orig_patent_app_number] => 10957427
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/957427 | Methods of therapy with thrombin derived peptides | Sep 29, 2004 | Issued |
Array
(
[id] => 446290
[patent_doc_number] => 07253147
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-08-07
[patent_title] => 'Modified serum albumin with reduced affinity for nickel and copper'
[patent_app_type] => utility
[patent_app_number] => 10/934401
[patent_app_country] => US
[patent_app_date] => 2004-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4923
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/253/07253147.pdf
[firstpage_image] =>[orig_patent_app_number] => 10934401
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/934401 | Modified serum albumin with reduced affinity for nickel and copper | Sep 6, 2004 | Issued |
Array
(
[id] => 7126960
[patent_doc_number] => 20050058704
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-17
[patent_title] => 'Capsule containing active substance pellets'
[patent_app_type] => utility
[patent_app_number] => 10/932839
[patent_app_country] => US
[patent_app_date] => 2004-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5130
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20050058704.pdf
[firstpage_image] =>[orig_patent_app_number] => 10932839
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/932839 | Capsule containing active substance pellets | Sep 1, 2004 | Abandoned |